LivaNova (LIVN) Non Operating Investment Income (2017 - 2018)

LivaNova (LIVN) reported Non Operating Investment Income of $11.5 million for Q1 2018, down 70.87% sequentially from $39.4 million in Q2 2017.

LivaNova (LIVN) Non Operating Investment Income (2017 - 2018) Analysis & Trends

LivaNova (LIVN) has 2 years of Non Operating Investment Income data on file, last reported at $11.5 million in Q1 2018.

  • For the quarter ending Q1 2018, Non Operating Investment Income changed N/A year-over-year to $11.5 million; the trailing twelve-month figure through Dec 2018 stood at $11.5 million (down 70.87% YoY), and the FY2018 full-year result was $11.5 million, down 70.87% from the prior year.
  • Non Operating Investment Income slipped to $11.5 million in Q1 2018, from $39.4 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $39.4 million in Q2 2017 to a low of $11.5 million in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 LivaNova 4.40 Bn 3.86 Bn 243.75 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2018 11.48 Mn
Mar 31, 2018 11.48 Mn
Jun 30, 2017 39.43 Mn
Jun 30, 2017 39.43 Mn